MYOM3 and Menkes disease: Furthermore, our biomarker-response study in 12-month-old dogs showed that serum CCL2, MYOM3 and MSTN concentrations are useful biomarkers of the DE50-MD phenotype that are unaffected (CCL2 and MYOM3) or minimally affected (MSTN) by the low levels of physical activity performed by this age group.